The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
Sponsored: Prioritize your mental health in 2026. If depression or OCD has clouded your mind, consider TMS Therapy.
Here in the U.S., some 21 million adults experience at least one major depressive episode each year. About a third of them do not achieve adequate relief from traditional antidepressant medications ...
With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes.” — Kerry Rome, SVP MagVenture, Inc.
BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
NEWPORT NEWS, Va., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers, one of the leading providers of mental health services in the United States, is now offering BrainsWay’s Deep ...
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRSYF) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...
Expert behavioral medicine specialists and neurologists at the WVU Rockefeller Neuroscience Institute (RNI) offer an alternative and complementary treatment option for adult patients who have major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback